We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $167B
1-Year Est. Return 44.17%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+44.17%
3 Year Est. Return
+189.18%
5 Year Est. Return
+274.73%
10 Year Est. Return
+1,810.98%
AUM
$167B
AUM Growth
-$5.21B
Cap. Flow
-$7.12B
Cap. Flow %
-4.28%
Top 10 Hldgs %
47.55%
Holding
652
New
92
Increased
209
Reduced
263
Closed
78

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.24B
2
NVDA icon
NVIDIA
NVDA
+$1.89B
3
MELI icon
Mercado Libre
MELI
+$1.5B
4
NFLX icon
Netflix
NFLX
+$1.32B
5
NKE icon
Nike
NKE
+$826M

Sector Composition

Rank Sector Weight
1 Technology 41.63%
2 Communication Services 15.64%
3 Consumer Discretionary 12.05%
4 Healthcare 9.65%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
576
Abbott
ABT
$187B
-290,085
Closed -$38.9M
ACHR icon
577
Archer Aviation
ACHR
$4.26B
-65,428
Closed -$627K
AIN icon
578
Albany International
AIN
$1.78B
-9,808
Closed -$523K
AKRO
579
DELISTED
Akero Therapeutics
AKRO
-139,366
Closed -$6.62M
ALEX
580
DELISTED
Alexander & Baldwin
ALEX
-108,897
Closed -$1.98M
ALKS icon
581
Alkermes
ALKS
$8.25B
-19,570
Closed -$587K
ALSN icon
582
Allison Transmission
ALSN
$9.82B
-9,339
Closed -$793K
AMLX icon
583
Amylyx Pharmaceuticals
AMLX
$2.54B
-578,659
Closed -$7.86M
ARES icon
584
Ares Management
ARES
$30.9B
-14,198
Closed -$2.27M
ASAN icon
585
Asana
ASAN
$2.13B
-56,410
Closed -$754K
ATEN icon
586
A10 Networks
ATEN
$1.95B
-47,445
Closed -$861K
AVDX
587
DELISTED
AvidXchange
AVDX
-673,130
Closed -$6.7M
BHVN icon
588
Biohaven
BHVN
$2.21B
-49,457
Closed -$742K
BMY icon
589
Bristol-Myers Squibb
BMY
$132B
-21,733
Closed -$980K
BUR icon
590
Burford Capital
BUR
$971M
-85,659
Closed -$1.02M
BV icon
591
BrightView Holdings
BV
$1.07B
-52,585
Closed -$705K
CAVA icon
592
CAVA Group
CAVA
$7.27B
-3,347
Closed -$202K
CCOI icon
593
Cogent Communications
CCOI
$508M
-342,316
Closed -$13.1M
CDTX
594
DELISTED
Cidara Therapeutics
CDTX
-396,015
Closed -$37.9M
CFLT
595
DELISTED
Confluent
CFLT
-634,133
Closed -$12.6M
CLSK icon
596
CleanSpark
CLSK
$3.16B
-39,935
Closed -$579K
CNMD icon
597
CONMED
CNMD
$1.47B
-19,960
Closed -$939K
CPRX
598
DELISTED
Catalyst Pharmaceutical
CPRX
-39,625
Closed -$781K
CRI icon
599
Carter's
CRI
$1.47B
-20,997
Closed -$593K
CWK icon
600
Cushman & Wakefield Ltd
CWK
$3.25B
-54,786
Closed -$872K

Similar funds

Jennison Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Jennison Associates held 652 positions worth $167B, down 3% from $172B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Jennison Associates withdrew a net $7.12B in Q4 2025, closing 78 positions and reducing 263 holdings. Its most notable exit was Nike, an estimated $826M position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 41% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Jennison Associates opened a new position in Merck worth $585M.

  • Jennison Associates's largest Q4 2025 buy was Merck: 5,559,488 shares worth $585M.
  • Jennison Associates added most to Advanced Micro Devices in Q4 2025, an estimated $1.58B increase.
  • Jennison Associates's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $2.24B.
  • Jennison Associates fully exited Nike in Q4 2025, selling an estimated $826M.
  • Jennison Associates's ten largest holdings make up 48% of its $167B portfolio in Q4 2025.
  • Jennison Associates opened 92 new positions and closed 78 in Q4 2025.
  • Jennison Associates's portfolio value fell 3% quarter-over-quarter to $167B.

Based on Jennison Associates's 13F filing for Q4 2025, filed 30 Jan 2026.